Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Clin Cancer Res April 15 2010 16 (8) 2227-2227;

Molecular Pathways

  • Molecular Pathways
    Signaling From the Golgi: Mechanisms and Models for Golgi Phosphoprotein 3–Mediated Oncogenesis
    Kenneth L. Scott and Lynda Chin
    Clin Cancer Res April 15 2010 16 (8) 2229-2234; DOI:10.1158/1078-0432.CCR-09-1695

Human Cancer Biology

  • Human Cancer Biology
    Synergistic Antitumor Effect of the Activated PPARγ and Retinoid Receptors on Human Osteosarcoma
    Bai-Cheng He, Liang Chen, Guo-Wei Zuo, Wenli Zhang, Yang Bi, Jiayi Huang, Yi Wang, Wei Jiang, Qing Luo, Qiong Shi, Bing-Qiang Zhang, Bo Liu, Xia Lei, Jinyong Luo, Xiaoji Luo, Eric R. Wagner, Stephanie H. Kim, Connie J. He, Yawen Hu, Jikun Shen, Qixin Zhou, Farbod Rastegar, Zhong-Liang Deng, Hue H. Luu, Tong-Chuan He and Rex C. Haydon
    Clin Cancer Res April 15 2010 16 (8) 2235-2245; DOI:10.1158/1078-0432.CCR-09-2499

  • Human Cancer Biology
    RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
    Clara Ricci, Elisa Fermo, Stefania Corti, Mauro Molteni, Alessio Faricciotti, Agostino Cortelezzi, Giorgio Lambertenghi Deliliers, Miloslav Beran and Francesco Onida
    Clin Cancer Res April 15 2010 16 (8) 2246-2256; DOI:10.1158/1078-0432.CCR-09-2112

  • Human Cancer Biology
    Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression
    Matthew J. Strouch, Eric C. Cheon, Mohammad R. Salabat, Seth B. Krantz, Elias Gounaris, Laleh G. Melstrom, Surabhi Dangi-Garimella, Edward Wang, Hidayatullah G. Munshi, Khashayarsha Khazaie and David J. Bentrem
    Clin Cancer Res April 15 2010 16 (8) 2257-2265; DOI:10.1158/1078-0432.CCR-09-1230

  • Human Cancer Biology
    Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance
    Michelle D. Williams, Dianna B. Roberts, Merrill S. Kies, Li Mao, Randal S. Weber and Adel K. El-Naggar
    Clin Cancer Res April 15 2010 16 (8) 2266-2274; DOI:10.1158/1078-0432.CCR-09-0238

  • Human Cancer Biology
    The EPHB6 Receptor Tyrosine Kinase Is a Metastasis Suppressor That Is Frequently Silenced by Promoter DNA Hypermethylation in Non–Small Cell Lung Cancer
    Jun Yu, Etmar Bulk, Ping Ji, Antje Hascher, Moying Tang, Ralf Metzger, Alessandro Marra, Hubert Serve, Wolfgang E. Berdel, Rainer Wiewroth, Steffen Koschmieder and Carsten Müller-Tidow
    Clin Cancer Res April 15 2010 16 (8) 2275-2283; DOI:10.1158/1078-0432.CCR-09-2000

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Selective Cytotoxicity to HER2-Positive Tumor Cells by a Recombinant e23sFv-TD-tBID Protein Containing a Furin Cleavage Sequence
    Fang Wang, Jing Ren, Xiu-Chun Qiu, Li-Feng Wang, Qing Zhu, Ying-Qi Zhang, Yi Huan, Yan-Ling Meng, Li-Bo Yao, Si-Yi Chen, Yan-Ming Xu and An-Gang Yang
    Clin Cancer Res April 15 2010 16 (8) 2284-2294; DOI:10.1158/1078-0432.CCR-09-2367

  • Cancer Therapy: Preclinical
    CK2 Modulation of NF-κB, TP53, and the Malignant Phenotype in Head and Neck Cancer by Anti-CK2 Oligonucleotides In vitro or In vivo via Sub–50-nm Nanocapsules
    Matthew S. Brown, Oumou T. Diallo, Michael Hu, Reza Ehsanian, Xinping Yang, Pattatheyil Arun, Hai Lu, Vicci Korman, Gretchen Unger, Khalil Ahmed, Carter Van Waes and Zhong Chen
    Clin Cancer Res April 15 2010 16 (8) 2295-2307; DOI:10.1158/1078-0432.CCR-09-3200

  • Cancer Therapy: Preclinical
    Targeted Cytosine Deaminase-Uracil Phosphoribosyl Transferase Suicide Gene Therapy Induces Small Cell Lung Cancer–Specific Cytotoxicity and Tumor Growth Delay
    Camilla L. Christensen, Torben Gjetting, Thomas T. Poulsen, Frederik Cramer, Jack A. Roth and Hans S. Poulsen
    Clin Cancer Res April 15 2010 16 (8) 2308-2319; DOI:10.1158/1078-0432.CCR-09-3057

  • Cancer Therapy: Preclinical
    Histone Deacetylase Inhibitors and 15-Deoxy-Δ12,14-Prostaglandin J2 Synergistically Induce Apoptosis
    Makoto Koyama, Yasuyuki Izutani, Ahmed E. Goda, Taka-aki Matsui, Mano Horinaka, Mitsuhiro Tomosugi, Jun Fujiwara, Yoshitaka Nakamura, Miki Wakada, Shingo Yogosawa, Yoshihiro Sowa and Toshiyuki Sakai
    Clin Cancer Res April 15 2010 16 (8) 2320-2332; DOI:10.1158/1078-0432.CCR-09-2301

  • Cancer Therapy: Preclinical
    T-Cell Receptor Gene–Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy
    Matthias Leisegang, Adriana Turqueti-Neves, Boris Engels, Thomas Blankenstein, Dolores J. Schendel, Wolfgang Uckert and Elfriede Noessner
    Clin Cancer Res April 15 2010 16 (8) 2333-2343; DOI:10.1158/1078-0432.CCR-09-2897

  • Cancer Therapy: Preclinical
    Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors
    Asima Mukhopadhyay, Ahmed Elattar, Aiste Cerbinskaite, Sarah J. Wilkinson, Yvette Drew, Suzanne Kyle, Gerrit Los, Zdenek Hostomsky, Richard J. Edmondson and Nicola J. Curtin
    Clin Cancer Res April 15 2010 16 (8) 2344-2351; DOI:10.1158/1078-0432.CCR-09-2758

  • Cancer Therapy: Preclinical
    Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors
    Fariba Némati, Xavier Sastre-Garau, Cécile Laurent, Jérôme Couturier, Pascale Mariani, Laurence Desjardins, Sophie Piperno-Neumann, Olivier Lantz, Bernard Asselain, Corine Plancher, Delphine Robert, Isabelle Péguillet, Marie-Hélène Donnadieu, Ahmed Dahmani, Marie-Andrée Bessard, David Gentien, Cécile Reyes, Simon Saule, Emmanuel Barillot, Sergio Roman-Roman and Didier Decaudin
    Clin Cancer Res April 15 2010 16 (8) 2352-2362; DOI:10.1158/1078-0432.CCR-09-3066

  • Cancer Therapy: Preclinical
    Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival
    Gaëlle Picarda, François Lamoureux, Loïc Geffroy, Pascal Delepine, Tristan Montier, Karine Laud, Franck Tirode, Olivier Delattre, Dominique Heymann and Françoise Rédini
    Clin Cancer Res April 15 2010 16 (8) 2363-2374; DOI:10.1158/1078-0432.CCR-09-1779

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment
    Higinio Dopeso, Silvia Mateo-Lozano, Elena Elez, Stefania Landolfi, Francisco Javier Ramos Pascual, Javier Hernández-Losa, Rocco Mazzolini, Paulo Rodrigues, Sarah Bazzocco, Maria Josep Carreras, Eloy Espín, Manel Armengol, Andrew J. Wilson, John M. Mariadason, Santiago Ramon y Cajal, Josep Tabernero, Simo Schwartz Jr. and Diego Arango
    Clin Cancer Res April 15 2010 16 (8) 2375-2382; DOI:10.1158/1078-0432.CCR-09-3275

  • Imaging, Diagnosis, Prognosis
    Cyclooxygenase-2 Genetic Variants Are Associated with Survival in Unresectable Locally Advanced Non–Small Cell Lung Cancer
    Nan Bi, Ming Yang, Li Zhang, Xiabin Chen, Wei Ji, Guangfei Ou, Dongxin Lin and Luhua Wang
    Clin Cancer Res April 15 2010 16 (8) 2383-2390; DOI:10.1158/1078-0432.CCR-09-2793

  • Imaging, Diagnosis, Prognosis
    ERBB2 and TOP2A in Breast Cancer: A Comprehensive Analysis of Gene Amplification, RNA Levels, and Protein Expression and Their Influence on Prognosis and Prediction
    Jan C. Brase, Marcus Schmidt, Thomas Fischbach, Holger Sültmann, Hans Bojar, Heinz Koelbl, Birte Hellwig, Jörg Rahnenführer, Jan G. Hengstler and Mathias C. Gehrmann
    Clin Cancer Res April 15 2010 16 (8) 2391-2401; DOI:10.1158/1078-0432.CCR-09-2471

  • Imaging, Diagnosis, Prognosis
    Serial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic Melanoma
    Kazuo Koyanagi, Steven J. O'Day, Peter Boasberg, Michael B. Atkins, He-Jing Wang, Rene Gonzalez, Karl Lewis, John A. Thompson, Clay M. Anderson, Jose Lutzky, Thomas T. Amatruda, Evan Hersh, Jon Richards, Jeffrey S. Weber and Dave S.B. Hoon
    Clin Cancer Res April 15 2010 16 (8) 2402-2408; DOI:10.1158/1078-0432.CCR-10-0037

  • Imaging, Diagnosis, Prognosis
    A Novel Prognostic Model for Malignant Mesothelioma Incorporating Quantitative FDG-PET Imaging with Clinical Parameters
    Anna K. Nowak, Roslyn J. Francis, Michael J. Phillips, Michael J. Millward, Agatha A. van der Schaaf, Jan Boucek, Arthur W. Musk, Melanie J. McCoy, Amanda Segal, Peter Robins and Michael J. Byrne
    Clin Cancer Res April 15 2010 16 (8) 2409-2417; DOI:10.1158/1078-0432.CCR-09-2313

  • Imaging, Diagnosis, Prognosis
    Long Interspersed Nuclear Element 1 Hypomethylation Is a Marker of Poor Prognosis in Stage IA Non–Small Cell Lung Cancer
    Kenichiro Saito, Kazuyuki Kawakami, Isao Matsumoto, Makoto Oda, Go Watanabe and Toshinari Minamoto
    Clin Cancer Res April 15 2010 16 (8) 2418-2426; DOI:10.1158/1078-0432.CCR-09-2819

  • Imaging, Diagnosis, Prognosis
    Nuclear Localization of Signal Transducer and Activator of Transcription 3 in Head and Neck Squamous Cell Carcinoma Is Associated with a Better Prognosis
    Eirini Pectasides, Ann-Marie Egloff, Clarence Sasaki, Panteleimon Kountourakis, Barbara Burtness, George Fountzilas, Urania Dafni, Thomas Zaramboukas, Theodoros Rampias, David Rimm, Jennifer Grandis and Amanda Psyrri
    Clin Cancer Res April 15 2010 16 (8) 2427-2434; DOI:10.1158/1078-0432.CCR-09-2658

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494
    Jane N. Winter, Shuli Li, Vikas Aurora, Daina Variakojis, Beverly Nelson, Maryla Krajewska, Lijun Zhang, Thomas M. Habermann, Richard I. Fisher, William R. Macon, Mukesh Chhanabhai, Raymond E. Felgar, Eric D. Hsi, L. Jeffrey Medeiros, James K. Weick, Edie A. Weller, Ari Melnick, John C. Reed, Sandra J. Horning and Randy D. Gascoyne
    Clin Cancer Res April 15 2010 16 (8) 2435-2442; DOI:10.1158/1078-0432.CCR-09-1219

  • Cancer Therapy: Clinical
    Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
    Stuart A. Grossman, Xiaobu Ye, Steven Piantadosi, Serena Desideri, Louis B. Nabors, Myrna Rosenfeld, Joy Fisher and for the NABTT CNS Consortium
    Clin Cancer Res April 15 2010 16 (8) 2443-2449; DOI:10.1158/1078-0432.CCR-09-3106

  • Cancer Therapy: Clinical
    A Phase II Study of PD-0325901, an Oral MEK Inhibitor, in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer
    Eric B. Haura, Alejandro D. Ricart, Timothy G. Larson, Philip J. Stella, Lyudmila Bazhenova, Vincent A. Miller, Roger B. Cohen, Peter D. Eisenberg, Paulina Selaru, Keith D. Wilner and Shirish M. Gadgeel
    Clin Cancer Res April 15 2010 16 (8) 2450-2457; DOI:10.1158/1078-0432.CCR-09-1920

  • Cancer Therapy: Clinical
    A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors
    Razelle Kurzrock, Amita Patnaik, Joseph Aisner, Terri Warren, Stephen Leong, Robert Benjamin, S. Gail Eckhardt, Joseph E. Eid, Gerard Greig, Kai Habben, Cinara D. McCarthy and Lia Gore
    Clin Cancer Res April 15 2010 16 (8) 2458-2465; DOI:10.1158/1078-0432.CCR-09-3220

  • Cancer Therapy: Clinical
    Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung Cancer
    Gregory A. Otterson, Miguel A. Villalona-Calero, William Hicks, Xueliang Pan, John A. Ellerton, Scott N. Gettinger and John R. Murren
    Clin Cancer Res April 15 2010 16 (8) 2466-2473; DOI:10.1158/1078-0432.CCR-09-3015

  • Cancer Therapy: Clinical
    Pharmacodynamic Trial of Nimotuzumab in Unresectable Squamous Cell Carcinoma of the Head and Neck: A SENDO Foundation Study
    Federico Rojo, Elías Gracias, Nadia Villena, Teresa Cruz, Josep Maria Corominas, Irene Corradino, Mercedes Cedeño, Clara Campas, Marta Osorio, Normando Iznaga, Beatriz Bellosillo, Ana Rovira, Silvia Marsoni, Pere Gascon, Sergio Serrano, Cristiana Sessa, Tania Crombet and Joan Albanell
    Clin Cancer Res April 15 2010 16 (8) 2474-2482; DOI:10.1158/1078-0432.CCR-09-3042

Back to top
PreviousNext
Clinical Cancer Research: 16 (8)
April 2010
Volume 16, Issue 8
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Signaling From the Golgi: Mechanisms and Models for Golgi Phosphoprotein 3–Mediated Oncogenesis
  • Selective Cytotoxicity to HER2-Positive Tumor Cells by a Recombinant e23sFv-TD-tBID Protein Containing a Furin Cleavage Sequence
  • Pharmacodynamic Trial of Nimotuzumab in Unresectable Squamous Cell Carcinoma of the Head and Neck: A SENDO Foundation Study
  • Nuclear Localization of Signal Transducer and Activator of Transcription 3 in Head and Neck Squamous Cell Carcinoma Is Associated with a Better Prognosis

Jump to

  • Highlights
  • Molecular Pathways
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement